191 related articles for article (PubMed ID: 32695818)
1. A Novel Prediction Model for Significant Liver Fibrosis in Patients with Chronic Hepatitis B.
Chen Y; Gong J; Zhou W; Jie Y; Li Z; Chong Y; Hu B
Biomed Res Int; 2020; 2020():6839137. PubMed ID: 32695818
[TBL] [Abstract][Full Text] [Related]
2. Applicability of liver stiffness measurement based nomograms to the assessments of hepatitis B related significant fibrosis and cirrhosis.
Ji SS; Jiang HD; Jiang JC; Li J; Lin ST; Chen B; Xu SH
Clin Chim Acta; 2019 Feb; 489():75-82. PubMed ID: 30471249
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive diagnosis of significant liver inflammation in patients with chronic hepatitis B in the indeterminate phase.
Zhan J; Wang J; Zhang Z; Xue R; Jiang S; Liu J; Liu Y; Zhu L; Xia J; Yan X; Ding W; Zhu C; Qiu Y; Li J; Huang R; Wu C
Virulence; 2023 Dec; 14(1):2268497. PubMed ID: 37938933
[TBL] [Abstract][Full Text] [Related]
4. Nomogram for predicting advanced liver fibrosis and cirrhosis in patients with chronic liver disease.
Ding R; Zhou X; Huang D; Wang Y; Li X; Yan L; Lu W; Yang Z; Zhang Z
BMC Gastroenterol; 2021 Apr; 21(1):190. PubMed ID: 33906623
[TBL] [Abstract][Full Text] [Related]
5. Nomogram for cirrhosis in patients with chronic hepatitis B: A simple self-assessed scale for individual risk of cirrhosis.
Zhang Z; Li J; Wang P; He T; Ouyang Y; Huang Y
Sci Rep; 2017 Dec; 7(1):17493. PubMed ID: 29235488
[TBL] [Abstract][Full Text] [Related]
6. Identification of pseudo-immune tolerance for chronic hepatitis B patients: Development and validation of a non-invasive prediction model.
Li S; Li Z; Du H; Zao X; Gan D; Yang X; Li X; Xing Y; Ye Y
Front Public Health; 2023; 11():1137738. PubMed ID: 37089512
[TBL] [Abstract][Full Text] [Related]
7. A Novel Diagnostic Nomogram for Noninvasive Evaluating Liver Fibrosis in Patients with Chronic Hepatitis B Virus Infection.
Cheng D; Wan G; Sun L; Wang X; Ou W; Xing H
Biomed Res Int; 2020; 2020():5218930. PubMed ID: 32596321
[TBL] [Abstract][Full Text] [Related]
8. Globulin-platelet model predicts significant fibrosis and cirrhosis in CHB patients with high HBV DNA and mildly elevated alanine transaminase levels.
Li Q; Lu C; Li W; Huang Y; Chen L
Clin Exp Med; 2018 Feb; 18(1):71-78. PubMed ID: 28884309
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of APRI and FIB-4 for noninvasive assessment of significant fibrosis and cirrhosis in HBeAg-negative CHB patients with ALT ≤ 2 ULN: A retrospective cohort study.
Li Q; Ren X; Lu C; Li W; Huang Y; Chen L
Medicine (Baltimore); 2017 Mar; 96(12):e6336. PubMed ID: 28328813
[TBL] [Abstract][Full Text] [Related]
10. Comparative evaluation of GPR versus APRI and FIB-4 in predicting different levels of liver fibrosis of chronic hepatitis B.
Liu DP; Lu W; Zhang ZQ; Wang YB; Ding RR; Zhou XL; Huang D; Li XF
J Viral Hepat; 2018 May; 25(5):581-589. PubMed ID: 29230907
[TBL] [Abstract][Full Text] [Related]
11. Value of gamma-glutamyltranspeptidase-to-platelet ratio in diagnosis of hepatic fibrosis in patients with chronic hepatitis B.
Hu YC; Liu H; Liu XY; Ma LN; Guan YH; Luo X; Ding XC
World J Gastroenterol; 2017 Nov; 23(41):7425-7432. PubMed ID: 29151696
[TBL] [Abstract][Full Text] [Related]
12. Development and external validation of a prognostic nomogram for acute decompensation of chronic hepatitis B cirrhosis.
Gao F; Li X; Wan G; Li Y; Zhang Q; Liu Y; Liu H; Li H; Wang X
BMC Gastroenterol; 2018 Dec; 18(1):179. PubMed ID: 30509201
[TBL] [Abstract][Full Text] [Related]
13. Liver fibrosis index-based nomograms for identifying esophageal varices in patients with chronic hepatitis B related cirrhosis.
Xu SH; Wu F; Guo LH; Zhang WB; Xu HX
World J Gastroenterol; 2020 Dec; 26(45):7204-7221. PubMed ID: 33362377
[TBL] [Abstract][Full Text] [Related]
14. Aspartate aminotransferase to platelet ratio can reduce the need for transient elastography in Chinese patients with chronic hepatitis B.
Yue W; Li Y; Geng J; Wang P; Zhang L
Medicine (Baltimore); 2019 Dec; 98(49):e18038. PubMed ID: 31804310
[TBL] [Abstract][Full Text] [Related]
15. Changes in APRI and FIB-4 in HBeAg-negative treatment-naive chronic hepatitis B patients with significant liver histological lesions receiving 5-year entecavir therapy.
Liu R; Guo J; Lu Y; Zhang L; Shen G; Wu S; Chang M; Hu L; Hao H; Li M; Xie Y
Clin Exp Med; 2019 Aug; 19(3):309-320. PubMed ID: 31111345
[TBL] [Abstract][Full Text] [Related]
16. The gamma-glutamyl transpeptidase-to-albumin ratio predicts significant fibrosis and cirrhosis in chronic hepatitis B patients.
Li Q; Lu C; Li W; Huang Y; Chen L
J Viral Hepat; 2017 Dec; 24(12):1143-1150. PubMed ID: 28685907
[TBL] [Abstract][Full Text] [Related]
17. Serum Biomarkers Predictive of Significant Fibrosis and Cirrhosis in Chronic Hepatitis B.
Lin CL; Liu CH; Wang CC; Liang CC; Su TH; Liu CJ; Kao JH
J Clin Gastroenterol; 2015 Sep; 49(8):705-13. PubMed ID: 25319739
[TBL] [Abstract][Full Text] [Related]
18. [Value of non-invasive models of liver fibrosis in judgment of treatment timing in chronic hepatitis B patients with ALT < 2×upper limit of normal].
Zhou QQ; Hu YB; Zhou K; Zhang WW; Li MH; Dong P; Di JG; Hong L; Du QW; Xie Y; Sun QF
Zhonghua Gan Zang Bing Za Zhi; 2016 Sep; 24(9):665-670. PubMed ID: 27788722
[No Abstract] [Full Text] [Related]
19. A novel non-invasive model for the prediction of advanced liver fibrosis in chronic hepatitis B patients with NAFLD.
Wang J; Huang R; Liu J; Lai R; Liu Y; Zhu C; Qiu Y; He Z; Yin S; Chen Y; Yan X; Ding W; Zheng Q; Li J; Wu C
J Viral Hepat; 2023 Apr; 30(4):287-296. PubMed ID: 36696366
[TBL] [Abstract][Full Text] [Related]
20. Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients.
Kim BK; Kim DY; Park JY; Ahn SH; Chon CY; Kim JK; Paik YH; Lee KS; Park YN; Han KH
Liver Int; 2010 Apr; 30(4):546-53. PubMed ID: 20074094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
